Meitav Investment House’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.19M | Hold |
33,400
| – | – | 0.06% | 96 |
|
2025
Q1 | $4.57M | Sell |
33,400
-69,438
| -68% | -$9.5M | 0.08% | 91 |
|
2024
Q4 | $15.7M | Buy |
102,838
+85,986
| +510% | +$13.1M | 0.27% | 73 |
|
2024
Q3 | $3.27M | Hold |
16,852
| – | – | 0.05% | 103 |
|
2024
Q2 | $3.91M | Buy |
16,852
+12
| +0.1% | +$2.78K | 0.07% | 97 |
|
2024
Q1 | $3.63M | Buy |
16,840
+40
| +0.2% | +$8.63K | 0.07% | 93 |
|
2023
Q4 | $4.35M | Buy |
16,800
+8
| +0% | +$2.07K | 0.06% | 121 |
|
2023
Q3 | $4.35M | Buy |
16,792
+2,667
| +19% | +$690K | 0.07% | 127 |
|
2023
Q2 | $3.99M | Hold |
14,125
| – | – | 0.06% | 139 |
|
2023
Q1 | $4.33M | Buy |
14,125
+5,600
| +66% | +$1.72M | 0.07% | 147 |
|
2022
Q4 | $2.36M | Hold |
8,525
| – | – | 0.04% | 176 |
|
2022
Q3 | $2.25M | Sell |
8,525
-8,468
| -50% | -$2.24M | 0.04% | 184 |
|
2022
Q2 | $3.47M | Buy |
16,993
+1,181
| +7% | +$241K | 0.06% | 159 |
|
2022
Q1 | $3.33M | Buy |
+15,812
| New | +$3.33M | 0.05% | 183 |
|
2021
Q3 | – | Sell |
-815
| Closed | -$282K | – | 407 |
|
2021
Q2 | $282K | Sell |
815
-800
| -50% | -$277K | 0.01% | 362 |
|
2021
Q1 | $449 | Sell |
1,615
-259
| -14% | -$72 | 0.01% | 283 |
|
2020
Q4 | $457K | Sell |
1,874
-100
| -5% | -$24.4K | 0.02% | 284 |
|
2020
Q3 | $558K | Sell |
1,974
-200
| -9% | -$56.5K | 0.03% | 242 |
|
2020
Q2 | $572K | Buy |
2,174
+1,374
| +172% | +$362K | 0.03% | 206 |
|
2020
Q1 | $253K | Sell |
800
-200
| -20% | -$63.3K | 0.02% | 310 |
|
2019
Q4 | $297K | Buy |
+1,000
| New | +$297K | 0.02% | 326 |
|
2019
Q1 | – | Sell |
-31,220
| Closed | -$9.4M | – | 392 |
|
2018
Q4 | $9.4M | Sell |
31,220
-46
| -0.1% | -$13.8K | 0.58% | 54 |
|
2018
Q3 | $11.1M | Sell |
31,266
-6,684
| -18% | -$2.38M | 0.54% | 50 |
|
2018
Q2 | $11M | Sell |
37,950
-270
| -0.7% | -$78.4K | 0.49% | 58 |
|
2018
Q1 | $10.5M | Buy |
38,220
+280
| +0.7% | +$76.7K | 0.53% | 56 |
|
2017
Q4 | $12.1M | Buy |
+37,940
| New | +$12.1M | 0.71% | 53 |
|